Patent 8933048 was granted and assigned to Case Western Reserve University on January, 2015 by the United States Patent and Trademark Office.
A method of treating a cardiomyopathy in a subject includes administering to the subject a therapeutically effective amount of an agent that modulates contractile function in myocardial tissue of the subject.